MENAFN.COM (MENAFN Editorial) Insulinoma Market Analysis: By Key Companies- Abcam plc cironpharma Pfizer Plc. Entax Medical Olympus By Types (Benign, Metastasize) By Diagnosis (Blood Test, Endoscopic Ultrasound, Computed Tomography (CT), Magnetic ... |
Feeds
4187 items (4187 unread) in 74 feeds
Acinar Cell Carcinoma
(30 unread)
Acinic Cell Carcinoma
(31 unread)
Adenoid Cystic Carcinoma
(64 unread)
Adrenal Gland Cancer
(323 unread)
Ampulla Of Vater
(31 unread)
Anal Cancer
(330 unread)
Angiosarcoma
(76 unread)
Appendix Cancer
(77 unread)
Bile Duct Cancer
(543 unread)
Brain and CNS
(743 unread)
Carcinoid
(112 unread)
Endocrine/Neuroendocrine
(381 unread)
Gall Bladder Cancer
(129 unread)
Hemangioendothelioma
(30 unread)
Hepatoblastoma
(32 unread)
Pancreas
(54 unread)
Phyllodes
(18 unread)
PMP and Mucinous Tumors
(15 unread)
Rhabdomyosarcoma
(87 unread)
Sarcoma
(1081 unread)
Google - Insulinoma (5 unread)
-
Absolute Study On Insulinoma Market: Worth USD 3.3 billion by 2023, at a CAGR of ~ 3.3 - MENAFN.COM
Posted: October 19th, 2017, 12:51am GMT
-
Insulinoma Market to Witness Comprehensive Growth USD 3.3 billion by 2023, at a CAGR of ~ 3.3 % - Digital Journal
Posted: October 12th, 2017, 2:20pm GMT
Insulinoma Market to Witness Comprehensive Growth USD 3.3 billion by 2023, at a CAGR of ~ 3.3 %
Digital Journal
Insulinoma Market Analysis: By Key Companies- Abcam plc cironpharma Pfizer Plc. Entax Medical Olympus By Types (Benign, Metastasize) By Diagnosis (Blood Test, Endoscopic Ultrasound, Computed Tomography (CT), Magnetic Resonance Imaging (MRI) ... -
Ultimate Analysis on Insulinoma Market: Valuation USD 3.3 billion by 2023, at a CAGR of ~ 3.3 % - Digital Journal
Posted: October 6th, 2017, 6:14pm GMT
Ultimate Analysis on Insulinoma Market: Valuation USD 3.3 billion by 2023, at a CAGR of ~ 3.3 %
Digital Journal
The symptoms of insulinoma are hypoglycaemia and associated symptoms such as blurred vision, lethargy, diplopia, light headedness, and convulsions, unconsciousness, which can also be life-threatening. Severe hypoglycemia may result in seizures, coma ... -
Rare Tumor May Point the Way to Diabetes Treatment - Doctors Lounge
Posted: October 5th, 2017, 11:24am GMT
Rare Tumor May Point the Way to Diabetes Treatment
Doctors Lounge
THURSDAY, Oct. 5, 2017 (HealthDay News) -- A rare, benign tumor that grows in the pancreas may give doctors the tools they need to help people with diabetes make more insulin. These tumors are called insulinomas because they secrete the hormone ...
and more » -
Glucagon-like Peptide 1–Receptor Scans to Localize Occult Insulinomas - New England Journal of Medicine (subscription)
Posted: August 13th, 2008, 7:13pm GMT
New England Journal of Medicine (subscription)Glucagon-like Peptide 1–Receptor Scans to Localize Occult Insulinomas
New England Journal of Medicine (subscription)
The precise localization of some insulinomas (islet-cell adenomas that secrete insulin) with the use of conventional imaging techniques, such as computed tomography (CT), magnetic resonance imaging (MRI), endosonography,1 and indium-111 ...